NewsRx

Search our medical news database

Biotechnology Business

Biopta Stretches Blood Vessel Viability Using Abcellute Cell Preservation Technology

Published in Hospital Business Week, December 2nd, 2007

Early stage studies using human tissue samples are increasingly recognised as key to reducing drug failure rates. Now in a major breakthrough Abcellute's non-cryogenic cell preservation technology has been successful trialled by Biopta Ltd, a CRO specializing in human tissue in vitro pharmacology. Biopta were able to use Abcellute's matrix to maintain the viability of fresh blood vessels over 5 days for use on their cardiovascular in vitro testing systems including Biopta's first instrument, the PM-1, which provides real-time information on the vascular effects of drugs in living tissues.

According to Dr Karen Macdonald of Biopta, the next stage is to repeat the trials...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook